These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 22523394)

  • 1. Blockade of cholesterol absorption by ezetimibe reveals a complex homeostatic network in enterocytes.
    Engelking LJ; McFarlane MR; Li CK; Liang G
    J Lipid Res; 2012 Jul; 53(7):1359-68. PubMed ID: 22523394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of intestinal LDLR by the LXR-IDOL axis.
    van Loon NM; van Wouw SAE; Ottenhoff R; Nelson JK; Kingma J; Scheij S; Moeton M; Zelcer N
    Atherosclerosis; 2020 Dec; 315():1-9. PubMed ID: 33190106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insig proteins mediate feedback inhibition of cholesterol synthesis in the intestine.
    McFarlane MR; Liang G; Engelking LJ
    J Biol Chem; 2014 Jan; 289(4):2148-56. PubMed ID: 24337570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the apical and basolateral domains of the enterocyte in the regulation of cholesterol transport by a high glucose concentration.
    Grenier E; Mailhot G; Dion D; Ravid Z; Spahis S; Bendayan M; Levy E
    Biochem Cell Biol; 2013 Dec; 91(6):476-86. PubMed ID: 24219290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.
    Kannisto K; Gåfvels M; Jiang ZY; Slätis K; Hu X; Jorns C; Steffensen KR; Eggertsen G
    Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic overexpression of idol increases circulating protein convertase subtilisin/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways.
    Sasaki M; Terao Y; Ayaori M; Uto-Kondo H; Iizuka M; Yogo M; Hagisawa K; Takiguchi S; Yakushiji E; Nakaya K; Ogura M; Komatsu T; Ikewaki K
    Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1171-8. PubMed ID: 24675665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe Promotes Brush Border Membrane-to-Lumen Cholesterol Efflux in the Small Intestine.
    Nakano T; Inoue I; Takenaka Y; Ono H; Katayama S; Awata T; Murakoshi T
    PLoS One; 2016; 11(3):e0152207. PubMed ID: 27023132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced VLDL clearance in Apoe(-/-)Npc1(-/-) mice is associated with increased Pcsk9 and Idol expression and decreased hepatic LDL-receptor levels.
    Ishibashi M; Masson D; Westerterp M; Wang N; Sayers S; Li R; Welch CL; Tall AR
    J Lipid Res; 2010 Sep; 51(9):2655-63. PubMed ID: 20562239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolin-1 is not required for murine intestinal cholesterol transport.
    Valasek MA; Weng J; Shaul PW; Anderson RG; Repa JJ
    J Biol Chem; 2005 Jul; 280(30):28103-9. PubMed ID: 15919660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane.
    Kramer W; Girbig F; Corsiero D; Pfenninger A; Frick W; Jähne G; Rhein M; Wendler W; Lottspeich F; Hochleitner EO; Orsó E; Schmitz G
    J Biol Chem; 2005 Jan; 280(2):1306-20. PubMed ID: 15494415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption.
    Altmann SW; Davis HR; Yao X; Laverty M; Compton DS; Zhu LJ; Crona JH; Caplen MA; Hoos LM; Tetzloff G; Priestley T; Burnett DA; Strader CD; Graziano MP
    Biochim Biophys Acta; 2002 Jan; 1580(1):77-93. PubMed ID: 11923102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy men.
    Gouni-Berthold I; Berthold HK; Gylling H; Hallikainen M; Giannakidou E; Stier S; Ko Y; Patel D; Soutar AK; Seedorf U; Mantzoros CS; Plat J; Krone W
    Atherosclerosis; 2008 May; 198(1):198-207. PubMed ID: 17980884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.
    Zelcer N; Hong C; Boyadjian R; Tontonoz P
    Science; 2009 Jul; 325(5936):100-4. PubMed ID: 19520913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol auxotrophy and intolerance to ezetimibe in mice with SREBP-2 deficiency in the intestine.
    Rong S; McDonald JG; Engelking LJ
    J Lipid Res; 2017 Oct; 58(10):1988-1998. PubMed ID: 28630260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels.
    Xie P; Zhu H; Jia L; Ma Y; Tang W; Wang Y; Xue B; Shi H; Yu L
    Atherosclerosis; 2014 Dec; 237(2):609-17. PubMed ID: 25463095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ezetimibe increases intestinal expression of the LDL receptor gene in dyslipidaemic men with insulin resistance.
    Drouin-Chartier JP; Tremblay AJ; Lemelin V; Lépine MC; Lamarche B; Couture P
    Diabetes Obes Metab; 2016 Dec; 18(12):1226-1235. PubMed ID: 27460541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Porphyromonas gingivalis infection on post-transcriptional regulation of the low-density lipoprotein receptor in mice.
    Miyazawa H; Tabeta K; Miyauchi S; Aoki-Nonaka Y; Domon H; Honda T; Nakajima T; Yamazaki K
    Lipids Health Dis; 2012 Sep; 11():121. PubMed ID: 22992388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol.
    Briand F; Naik SU; Fuki I; Millar JS; Macphee C; Walker M; Billheimer J; Rothblat G; Rader DJ
    Clin Transl Sci; 2009 Apr; 2(2):127-33. PubMed ID: 20169010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SREBP-1c gene polymorphism is associated with increased inhibition of cholesterol-absorption in response to ezetimibe treatment.
    Berthold HK; Laaksonen R; Lehtimäki T; Gylling H; Krone W; Gouni-Berthold I
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):262-7. PubMed ID: 18072016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The liver X receptors and sterol regulatory element binding proteins alter progesterone secretion and are regulated by human chorionic gonadotropin in human luteinized granulosa cells.
    Xu Y; Hernández-Ledezma JJ; Hutchison SM; Bogan RL
    Mol Cell Endocrinol; 2018 Sep; 473():124-135. PubMed ID: 29366778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.